Pelion S.A. (formerly Polska Grupa Farmaceutyczna S.A.) is a healthcare company that has been a prominent player in the market for twenty-five years. Operating in Poland, Lithuania, and the United Kingdom, the Pelion Healthcare Group is a major presence in the healthcare industry, with services encompassing wholesale, retail, and hospital sales targeting individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all aspects of the group's operations, managed by various entities including Polska Grupa Farmaceutyczna S.A. (wholesale), Pharmapoint Sp. z o.o. (pre-wholesale), PGF Urtica Sp. z o.o. (hospital supplies), CEPD N.V. (retail), and Pharmalink Sp. z o.o. (services for manufacturers). Founded in 1990, the company operates in the Health Care and Pharmaceutical industries and is headquartered in Poland. In its latest funding round on 20 December 2023, Pelion S.A. secured a €25.00M debt financing investment from the European Bank for Reconstruction and Development. This investment reflects the confidence of a respected investor in the company's potential and the healthcare market where it operates. The company's steady growth and diversification across multiple healthcare segments make it an attractive investment opportunity. With its strong market presence and strategic positioning, Pelion S.A. is poised for further expansion and success in the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | €25.00M | 1 | European Bank for Reconstruction and Development | 20 Dec 2023 |
No recent news or press coverage available for Pelion S.A..